CLINICAL_TRIALS
research
· 2025-11-05
Clinical Trial Update: DORA and LP in Alzheimer's Disease Biomarkers [Phase 2]
Summary
A Phase 2 clinical trial update for Alzheimer's disease evaluating DORA and LP in biomarkers; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Alzheimer Disease | Phase 2 | Status: RECRUITING